IRIS Accounts Production v26.1.10.61 SC834198 Board of Directors 15.1.25 31.3.26 31.3.26 0 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh SC834198 2025-01-14 SC834198 2026-03-31 SC834198 2025-01-15 2026-03-31 SC834198 2025-01-14 SC834198 ns15:Scotland 2025-01-15 2026-03-31 SC834198 ns14:PoundSterling 2025-01-15 2026-03-31 SC834198 ns10:Director1 2025-01-15 2026-03-31 SC834198 ns10:PrivateLimitedCompanyLtd 2025-01-15 2026-03-31 SC834198 ns10:SmallEntities 2025-01-15 2026-03-31 SC834198 ns10:AuditExempt-NoAccountantsReport 2025-01-15 2026-03-31 SC834198 ns10:SmallCompaniesRegimeForDirectorsReport 2025-01-15 2026-03-31 SC834198 ns10:SmallCompaniesRegimeForAccounts 2025-01-15 2026-03-31 SC834198 ns10:FullAccounts 2025-01-15 2026-03-31 SC834198 ns10:Director2 2025-01-15 2026-03-31 SC834198 ns10:RegisteredOffice 2025-01-15 2026-03-31 SC834198 ns5:CurrentFinancialInstruments 2026-03-31 SC834198 ns5:ShareCapital 2026-03-31 SC834198 ns5:RetainedEarningsAccumulatedLosses 2026-03-31 SC834198 ns5:ComputerEquipment 2025-01-15 2026-03-31 SC834198 ns5:ComputerEquipment 2026-03-31 SC834198 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-03-31 SC834198 ns5:DeferredTaxation 2025-01-15 2026-03-31 SC834198 ns5:DeferredTaxation 2026-03-31 SC834198 ns5:RetainedEarningsAccumulatedLosses 2025-01-15 2026-03-31

REGISTERED NUMBER: SC834198 (Scotland)

| Unaudited Financial Statements |

| for the Period |

| 15 January 2025 to 31 March 2026 |

| for |

| Midfield Medical Limited |

| Midfield Medical Limited (Registered number: SC834198) |

Contents of the Financial Statements

for the Period 15 January 2025 to 31 March 2026

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| Midfield Medical Limited |

Company Information

for the Period 15 January 2025 to 31 March 2026

| DIRECTORS: | Dr D A J Smith

| Dr G B Fleming

| REGISTERED OFFICE: | 90 Lasswade Road

| Edinburgh

| EH16 6SU

| REGISTERED NUMBER: | SC834198 (Scotland)

| ACCOUNTANTS: | A H & Co Ltd

| Chartered Accountants

| 6 Logie Mill

| Edinburgh

| Lothian

| EH7 4HG

| Midfield Medical Limited (Registered number: SC834198) |

Balance Sheet

31 March 2026

| Notes | £ | £ |

| FIXED ASSETS

| Tangible assets | 4 | 746 |  |

| CURRENT ASSETS

| Debtors | 5 | 5,210 |  |  |

| Cash at bank | 24,438 |  |  |

29,648 |  |

| CREDITORS

| Amounts falling due within one year | 6 | 7,757 |  |

| NET CURRENT ASSETS | 21,891 |  |

| TOTAL ASSETS LESS CURRENT LIABILITIES | 22,637 |  |

| PROVISIONS FOR LIABILITIES | 7 | 142 |  |

| NET ASSETS | 22,495 |  |

| CAPITAL AND RESERVES

| Called up share capital | 8 | 100 |  |

| Retained earnings | 9 | 22,395 |  |

22,495 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 June 2026 and were signed on its behalf by:

Dr D A J Smith - Director

| Midfield Medical Limited (Registered number: SC834198) |

Notes to the Financial Statements

for the Period 15 January 2025 to 31 March 2026

1. | STATUTORY INFORMATION

| Midfield Medical Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is stated net of trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the balance sheet date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the balance sheet date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

| Tangible fixed assets

| Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is

| provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less

| residual value, of each asset on a straight line basis over it's expected useful life, as follows:

| Computer Equipment - 20% on cost

| Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

| Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

| Financial instruments

| The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Midfield Medical Limited (Registered number: SC834198) |

Notes to the Financial Statements - continued

for the Period 15 January 2025 to 31 March 2026

2. | ACCOUNTING POLICIES - continued

| Provisions

| Provisions are recognised when the company has a present obligation (legal or constructive) as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

| The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation.

| Exemption from preparing a cash flow statement

| Exemption has been taken from preparing a cash flow statement on the grounds that the company qualifies as a small company.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was NIL.

4. | TANGIBLE FIXED ASSETS

| Computer

| equipment

£ |

| COST

| Additions | 984 |  |

| At 31 March 2026 | 984 |  |

| DEPRECIATION

| Charge for period | 238 |  |

| At 31 March 2026 | 238 |  |

| NET BOOK VALUE

| At 31 March 2026 | 746 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Other debtors | 5,210 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Taxation and social security | 5,111 |  |

| Other creditors | 2,646 |  |

7,757 |  |

7. | PROVISIONS FOR LIABILITIES

£ |

| Deferred tax | 142 |  |

| Deferred |

| tax |

£ |

| Provided during period | 142 |  |

| Balance at 31 March 2026 | 142 |  |

| Midfield Medical Limited (Registered number: SC834198) |

Notes to the Financial Statements - continued

for the Period 15 January 2025 to 31 March 2026

8. | CALLED UP SHARE CAPITAL

| Alloted, issued and fully paid |  |

| Number: |  | Class: |  | Nominal Value: |  |  | £ |  |

| 850 |  | Ordinary A Shares |  | 0.1 |  |  | 85 |  |

| 50 |  | Ordinary B Shares |  | 0.1 |  |  | 5 |  |

| 50 |  | Ordinary C Shares |  | 0.1 |  |  | 5 |  |

| 50 |  | Ordinary D Shares |  | 0.1 |  |  | 5 |  |

| 100 |  |

9. | RESERVES

| Retained

| earnings

£ |

| Profit for the period | 22,395 |  |

| At 31 March 2026 | 22,395 |  |

10. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| As at 31 March 2026, the company owed the directors £666.

11. | RELATED PARTY DISCLOSURES

| There were no related party transactions in the year.

12. | ULTIMATE CONTROLLING PARTY

| There is no ultimate controlling party.